Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey

Documenti analoghi

• Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
  di: Sara Ellegaard Paaske, et al.
  Pubblicazione: (2026)
• Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study
  di: Sara Ellegaard Paaske, et al.
  Pubblicazione: (2025)
• Response to the Letter of Dr. Renu Sah et al.
  di: Bénédicte Pigneur, et al.
  Pubblicazione: (2025)
• Nasogastric Delivery of Fecal Microbiota Transplantation for the Treatment of Fulminant Clostridioides difficile Infection: A Case Report
  di: Amitjeet Singh, et al.
  Pubblicazione: (2025)
• Clostridioides difficile Infection Risk in Children Prescribed Antibiotics for Tonsillectomy
  di: Erin M. Gawel, et al.
  Pubblicazione: (2025)